Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Coutant

Showing results (61-70 of 189) with videos related to

Pageof 19
Sort By:
Preventive Medicine Reports|June 9, 2023
Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, FranceClémence Feron Agbo, Emerline Assogba, Aurélie Bertaut, et al.
Breast Cancer Research and Treatment|December 14, 2011
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictorsAlbane Frati, Elisabeth Chereau, Charles Coutant, et al.
Annals of Surgical Oncology|March 5, 2013
The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter studyYann Delpech, Alexandre Bricou, Ruben Lousquy, et al.
Breast (Edinburgh, Scotland)|August 7, 2012
Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year studySéverine Guiu, Laurent Arnould, Franck Bonnetain, et al.
Breast Cancer Research and Treatment|March 15, 2008
Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter studyCharles Coutant, Roman Rouzier, Eric Fondrinier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancerJae K Lee, Charles Coutant, Young-Chul Kim, et al.
BMC Bioinformatics|March 28, 2008
Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responsesRené Natowicz, Roberto Incitti, Euler Guimarães Horta, et al.
Bulletin Du Cancer|October 1, 2015
[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer]Stéphane Konan, Vincent Goussot, Isabelle Desmoulins, et al.
BMJ Open|September 28, 2022
Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocolEmerline L F Assogba, Agnès Dumas, Anne-Sophie Woronoff, et al.
Trials|June 18, 2020
Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trialAriane Mamguem Kamga, Cyril Di Martino, Amelie Anota, et al.
Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:
Pageof 19
Preventive Medicine Reports|June 9, 2023
Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, FranceClémence Feron Agbo, Emerline Assogba, Aurélie Bertaut, et al.
Breast Cancer Research and Treatment|December 14, 2011
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictorsAlbane Frati, Elisabeth Chereau, Charles Coutant, et al.
Annals of Surgical Oncology|March 5, 2013
The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter studyYann Delpech, Alexandre Bricou, Ruben Lousquy, et al.
Breast (Edinburgh, Scotland)|August 7, 2012
Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year studySéverine Guiu, Laurent Arnould, Franck Bonnetain, et al.
Breast Cancer Research and Treatment|March 15, 2008
Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter studyCharles Coutant, Roman Rouzier, Eric Fondrinier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancerJae K Lee, Charles Coutant, Young-Chul Kim, et al.
BMC Bioinformatics|March 28, 2008
Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responsesRené Natowicz, Roberto Incitti, Euler Guimarães Horta, et al.
Bulletin Du Cancer|October 1, 2015
[Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer]Stéphane Konan, Vincent Goussot, Isabelle Desmoulins, et al.
BMJ Open|September 28, 2022
Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocolEmerline L F Assogba, Agnès Dumas, Anne-Sophie Woronoff, et al.
Trials|June 18, 2020
Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trialAriane Mamguem Kamga, Cyril Di Martino, Amelie Anota, et al.
Pageof 19